BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11512366)

  • 1. Differential telomerase expression and telomere length in primary intracranial tumors.
    Chen HJ; Cho CL; Liang CL; Chen L; Chang HW; Lu K; Lee TC
    Chang Gung Med J; 2001 Jun; 24(6):352-60. PubMed ID: 11512366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomerase activity and alterations in telomere length in human brain tumors.
    Hiraga S; Ohnishi T; Izumoto S; Miyahara E; Kanemura Y; Matsumura H; Arita N
    Cancer Res; 1998 May; 58(10):2117-25. PubMed ID: 9605755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implication of telomerase activity and alternations of telomere length in the histologic characteristics of intracranial meningiomas.
    Chen HJ; Liang CL; Lu K; Lin JW; Cho CL
    Cancer; 2000 Nov; 89(10):2092-8. PubMed ID: 11066050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation between telomerase activity, hTERT and telomere length for intracranial tumours.
    Maes L; Van Neste L; Van Damme K; Kalala JP; De Ridder L; Bekaert S; Cornelissen M
    Oncol Rep; 2007 Dec; 18(6):1571-6. PubMed ID: 17982646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implication of telomere length as a proliferation-associated marker in schwannomas.
    Chen HJ; Cho CL; Liang CL; Lu K; Lin JW
    J Surg Oncol; 2002 Oct; 81(2):93-100; discussion 100. PubMed ID: 12355410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
    Engelhardt M; Drullinsky P; Guillem J; Moore MA
    Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between telomere length and telomerase activity in gynecologic cancers.
    Wang SJ; Sakamoto T; Yasuda Si S; Fukasawa I; Ota Y; Hayashi M; Okura T; Zheng JH; Inaba N
    Gynecol Oncol; 2002 Jan; 84(1):81-4. PubMed ID: 11748981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meningiomas, dicentric chromosomes, gliomas, and telomerase activity.
    Carroll T; Maltby E; Brock I; Royds J; Timperley W; Jellinek D
    J Pathol; 1999 Aug; 188(4):395-9. PubMed ID: 10440750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomerase in intracranial meningiomas.
    Boldrini L; Pistolesi S; Gisfredi S; Ursino S; Lupi G; Caniglia M; Pingitore R; Basolo F; Parenti G; Fontanini G
    Int J Mol Med; 2003 Dec; 12(6):943-7. PubMed ID: 14612971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomerase activity in giant cell tumors of bone.
    Matsuo T; Hiyama E; Sugita T; Shimose S; Kubo T; Mochizuki Y; Adachi N; Kojima K; Sharman P; Ochi M
    Ann Surg Oncol; 2007 Oct; 14(10):2896-902. PubMed ID: 17653593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomerase activity and telomere length in lymphocytes from patients with cutaneous T-cell lymphoma.
    Wu K; Lund M; Bang K; Thestrup-Pedersen K
    Cancer; 1999 Sep; 86(6):1056-63. PubMed ID: 10491534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomere maintenance in childhood primitive neuroectodermal brain tumors.
    Didiano D; Shalaby T; Lang D; Grotzer MA
    Neuro Oncol; 2004 Jan; 6(1):1-8. PubMed ID: 14769133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase expression in gliomas including the nonastrocytic tumors.
    Chong EY; Lam PY; Poon WS; Ng HK
    Hum Pathol; 1998 Jun; 29(6):599-603. PubMed ID: 9635680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlations of telomere length, telomerase activity, and telomeric-repeat binding factor 1 expression in colorectal carcinoma.
    Garcia-Aranda C; de Juan C; Diaz-Lopez A; Sanchez-Pernaute A; Torres AJ; Diaz-Rubio E; Balibrea JL; Benito M; Iniesta P
    Cancer; 2006 Feb; 106(3):541-51. PubMed ID: 16388518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of telomerase RNA, telomerase activity, and telomere length in human gliomas.
    Morii K; Tanaka R; Onda K; Tsumanuma I; Yoshimura J
    Biochem Biophys Res Commun; 1997 Oct; 239(3):830-4. PubMed ID: 9367854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomerase activity in ovarian tumors.
    Murakami J; Nagai N; Ohama K; Tahara H; Ide T
    Cancer; 1997 Sep; 80(6):1085-92. PubMed ID: 9305709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomerase activity and telomere length in primary and metastatic tumors from pediatric bone cancer patients.
    Sotillo-Piñeiro E; Sierrasesúmaga L; Patiñno-García A
    Pediatr Res; 2004 Feb; 55(2):231-5. PubMed ID: 14630995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical usefulness of telomerase activation and telomere length in head and neck cancer.
    Patel MM; Parekh LJ; Jha FP; Sainger RN; Patel JB; Patel DD; Shah PM; Patel PS
    Head Neck; 2002 Dec; 24(12):1060-7. PubMed ID: 12454944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between telomerase expression and terminal restriction fragment length ratio in non-small cell lung cancer--an adjusted measurement and its clinical significance.
    Hsu CP; Miaw J; Shai SE; Chen CY
    Eur J Cardiothorac Surg; 2004 Aug; 26(2):425-31. PubMed ID: 15296909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomere length and telomerase activity in extra-abdominal desmoid tumors.
    Matsuo T; Hiyama E; Sugita T; Shimose S; Kubo T; Mochizuki Y; Adachi N; Ochi M
    Anticancer Res; 2007; 27(1A):411-5. PubMed ID: 17352261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.